We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New use for old drugs: Epirubicin in colorectal cancer.
- Authors
Tarpgaard, Line S.; Qvortrup, Camilla; Nielsen, Signe L.; Stenvang, Jan; Detlefsen, Sönke; Brünner, Nils; Pfeiffer, Per
- Abstract
In the article, the authors present their phase II study on the effectiveness of epirubicin in patients with oxaliplatin refractory metastatic colorectal cancer (mCRC). Topics include the routine clinical management of mCRC patients like oxaliplatin-containing therapy and irinotecan-containing therapy at progression and the proof of effective therapy like overall survival (OS) and progression-free survival (PFS).
- Subjects
DRUG efficacy; SURVIVAL; DISEASE progression; CLINICAL trials; COLORECTAL cancer; TREATMENT effectiveness; DISEASE relapse; EPIRUBICIN; OXALIPLATIN; GENE amplification; COMPUTED tomography; DRUG resistance in cancer cells; DRUG toxicity; EVALUATION
- Publication
Acta Oncologica, 2021, Vol 60, Issue 7, p954
- ISSN
0284-186X
- Publication type
Article
- DOI
10.1080/0284186X.2021.1904519